Orthobiologics Market Is Expected to Grow at a CAGR of 5.9% from 2013 to 2019
The global orthobiologics market is predicted to testify frequent product approval. This could be evident with the launch of NuVasive's AttraX Putty, a next-gen biologics technology in 2016. The product was introduced with the intention of gaining an edge over competitors and expanding the company's product portfolio. In a report by Transparency Market Research (TMR), leading players such as Globus Medical Inc., DePuy Synthes Inc., and Bacterin International Inc. have been profiled while focusing on their key developments and other...
View full press release